CVS strikes deal with activist Glenview Capital for four board seats

By CNBC | Nov 18, 2024 at 08:59 AM EST

CVS Health reached a deal with Glenview Capital for four board seats after the ousting of former chief Karen Lynch. Glenview CEO Larry Robbins and three other directors will join the board to enhance value for stakeholders. CVS faces challenges and cost-cutting measures amid activist settlements in the industry.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.